May 05, 2016
690:493
For every 493 shares held, investors received 690. The price per share adjusted from $25.13 to $17.96.
The split itself did not change the total investment value.
Staidson (Beijing) Biopharmaceuticals Co. Ltd. Class A (SZSE:300204) operates in the Pharmaceuticals: major industry.
Staidson (Beijing) Biopharmaceuticals Co. Ltd. Class A company overviewStaidson (Beijing) Biopharmaceuticals Co. Ltd. Class A's most recent stock split was on May 5, 2016. It was a 690-for-493 forward split, so shareholders received 690 shares for every 493 they held.
Staidson (Beijing) Biopharmaceuticals Co. Ltd. Class A (SZSE:300204) has split its stock 4 times: a 2-for-1 split on April 27, 2012, a 9-for-5 split on June 3, 2013, a 7-for-5 split on April 9, 2015, and a 690-for-493 split on May 5, 2016.
Staidson (Beijing) Biopharmaceuticals Co. Ltd. Class A has split its stock 4 times. This history records 4 forward splits between April 27, 2012 and May 5, 2016.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Staidson (Beijing) Biopharmaceuticals Co. Ltd. Class A's 690-for-493 split on May 5, 2016, every 493 shares became 690 shares.
Staidson (Beijing) Biopharmaceuticals Co. Ltd. Class A has not announced a new split in our records. Its most recent split was on May 5, 2016, 10 years ago. Companies announce splits in advance, and any new SZSE:300204 split will appear on this page.
Already premium?